Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,051 | 99 | 68.4% |
| Consulting Fee | $2,800 | 1 | 31.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,088 | 5 | $0 (2019) |
| Amgen Inc. | $1,748 | 22 | $0 (2022) |
| ABBVIE INC. | $1,384 | 34 | $0 (2024) |
| Lilly USA, LLC | $871.47 | 14 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $621.01 | 6 | $0 (2023) |
| UCB, Inc. | $262.03 | 2 | $0 (2024) |
| Lundbeck LLC | $249.97 | 3 | $0 (2024) |
| Allergan, Inc. | $203.78 | 8 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $149.34 | 1 | $0 (2023) |
| Depomed, Inc. | $125.00 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,211 | 24 | ABBVIE INC. ($824.25) |
| 2023 | $877.66 | 15 | AbbVie Inc. ($394.00) |
| 2022 | $1,002 | 16 | Amgen Inc. ($338.46) |
| 2021 | $165.51 | 4 | Biohaven Pharmaceuticals, Inc. ($73.94) |
| 2020 | $239.40 | 5 | Amgen Inc. ($134.58) |
| 2019 | $4,360 | 22 | Novartis Pharmaceuticals Corporation ($3,088) |
| 2018 | $812.40 | 11 | Amgen Inc. ($660.01) |
| 2017 | $182.90 | 3 | Depomed, Inc. ($125.00) |
All Payment Transactions
100 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $74.98 | General |
| Category: NEUROLOGY | ||||||
| 11/21/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: NEUROLOGY | ||||||
| 11/20/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $137.04 | General |
| Category: Neurology | ||||||
| 11/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $71.38 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/14/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $35.74 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $117.02 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $31.60 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.44 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.99 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $67.50 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/31/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: NEUROSCIENCE | ||||||
| 01/31/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $4.13 | General |
| Category: NEUROSCIENCE | ||||||
| 01/11/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: NEUROLOGY | ||||||
| 12/14/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $117.68 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 96 | 172 | $57,015 | $14,593 |
| 2022 | 2 | 101 | 186 | $54,497 | $14,509 |
| 2021 | 3 | 107 | 132 | $29,337 | $9,940 |
| 2020 | 3 | 103 | 142 | $40,843 | $10,066 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Facility | 2023 | 35 | 80 | $37,600 | $8,218 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 61 | 92 | $19,415 | $6,375 | 32.8% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Facility | 2022 | 31 | 89 | $41,830 | $8,263 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 70 | 97 | $12,667 | $6,246 | 49.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 71 | 84 | $10,806 | $6,098 | 56.4% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Facility | 2021 | 25 | 37 | $17,390 | $3,419 | 19.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 11 | 11 | $1,141 | $422.84 | 37.1% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Facility | 2020 | 34 | 70 | $32,900 | $6,755 | 20.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 43 | 45 | $5,613 | $2,227 | 39.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 26 | 27 | $2,330 | $1,084 | 46.5% |
About Dr. Charles Schultz, MD
Dr. Charles Schultz, MD is a Neurology healthcare provider based in Ann Arbor, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386693653.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Schultz, MD has received a total of $8,851 in payments from pharmaceutical and medical device companies, with $1,211 received in 2024. These payments were reported across 100 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($6,051).
As a Medicare-enrolled provider, Schultz has provided services to 407 Medicare beneficiaries, totaling 632 services with total Medicare billing of $49,107. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Pain Medicine, Clinical Neurophysiology
- Location Ann Arbor, MI
- Active Since 05/06/2006
- Last Updated 01/16/2013
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1386693653
Products in Payments
- AIMOVIG (Biological) $3,088
- Aimovig (Biological) $1,705
- BOTOX (Biological) $688.70
- QULIPTA (Drug) $541.24
- EMGALITY (Drug) $355.55
- VYEPTI (Biological) $249.97
- UBRELVY (Drug) $201.30
- AJOVY (Drug) $188.17
- SOLIRIS (Biological) $149.34
- AJOVY (Biological) $148.45
- Briviact (Drug) $137.04
- AUSTEDO (Drug) $126.00
- Cambia (Drug) $125.00
- Nayzilam (Drug) $124.99
- NURTEC ODT (Drug) $73.94
- ELYXYB - CELECOXIB (Drug) $46.13
- BOTOX NEURO REHAB (Drug) $41.86
- BOTOX THERAPEUTIC (Biological) $32.66
- BOTOX-NEUROLOGY (Drug) $16.04
- APTIOM (Drug) $14.86
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Ann Arbor
Wade Cooper, Do, DO
Neurology — Payments: $692,532
James Weintraub, D.o, D.O
Neurology — Payments: $310,749
Roger Albin, Md, MD
Neurology — Payments: $36,588
Matthew Lorincz, Md, MD
Neurology — Payments: $36,085
Dr. Denise Leung, M.d, M.D
Neurology — Payments: $20,721
Dawn Kleindorfer, Md, MD
Neurology — Payments: $13,978